期刊文献+

替勃龙临床应用研究进展 被引量:7

下载PDF
导出
摘要 替勃龙是一种组织选择性雌激素活性调节剂,本身激素活性很弱,主要依赖于组织局部酶的活性和组织的特异性代谢机制,在不同组织发挥不同的效应。现主要应用于围绝经期缓解血管舒缩症状,改善绝经后泌尿生殖道萎缩症状,预防骨质丢失,降低骨折的发生率,提高性功能,稳定情绪。其可能改善围绝经期功能性消化不良患者的胆囊动力以及治疗绝经后加重的偏头痛。对乳腺密度无明显影响,不增加乳腺癌的发生率,但可能增加乳腺癌的复发率,替勃龙仍然为乳腺癌患者使用的禁忌证。对子宫内膜无不利影响,不增加绝经后妇女深静脉血栓的发生率,但可能会增加心脑血管意外的风险。替勃龙应避免用于存在心脑血管意外高危因素的老年妇女。
作者 熊敏 黄薇
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2011年第8期580-583,共4页 Journal of Practical Obstetrics and Gynecology
  • 相关文献

参考文献20

  • 1Swanson SG, Drosman S, Helmond FA, et al. Tibolone for the treat- ment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study [ J ]. Menopause,2006, 13 (6) : 917 - 925.
  • 2Landgren MB, Bennink HJ, Helmond FA, et al. Dose-response analysis of effects of tibolone on climacteric symptoms [ J]. BJOG, 2002,109(10) : 1109 -1114.
  • 3Hammar ML, van-de-Weijer P, Franke HR. Tibolone and low-dose continuous combined hormone treatment:vaginal bleeding pattern, efficacy and tolerability[ J]. BJOG ,2007,114 ( 12 ) : 1522 - 1529.
  • 4Cummings SR,Ettinger B,Delmas PD,et al. The effects of tibolone in older postmenopausal women [ J ]. New Engl J Med, 2008,359 (7) : 697 - 708.
  • 5Nijland EA, Weijmar-Schultz WC, Davis SR. Effects of tibolone and raloxifene on health-related quality of life and sexual function [ J ].Maturitas,2007,58(2) : 164 - 173.
  • 6Nijland EA, Weijmar Schultz WC, Nathorst-BoSs J, et al. Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial[ J]. J Sex Med ,2008,5 (3) :646 - 656.
  • 7Nappi RE, Sances G, Sommacal A, et al. Different effects of tibolone and low-dose EPT in the management of postmenopausal women with primary headaches [ J ]. Menopause,2006,13 (5) : 818 - 825.
  • 8古赛,唐承薇,钟晓明,黄晓玲.替勃龙联合西沙必利改善绝经期妇女胆囊动力[J].重庆医科大学学报,2003,28(2):192-194. 被引量:1
  • 9古赛,唐承薇.替勃龙改善绝经期功能性消化不良症状[J].重庆医科大学学报,2003,28(4):487-490. 被引量:3
  • 10Eilertsen AL, Karssemeijer N, Skaane P, et al. Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method [ J ]. Menopause,2008,115 (6) :773 - 119.

二级参考文献13

共引文献2

同被引文献58

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部